IMMUNOSTEP mission is to develop and market innovative products that improve diagnostic and clinical research performance and we will continue to work every day to deliver high-quality technology in order to fight against the global health emergency by assuring reliable results.
Indirect Enzyme Immunoassay for detection of IgG antibodies agains Mpro specific protein of SARS-CoV-2
Indirect Enzyme Immunoassay for detection of IgA antibodies agains Mpro specific protein of SARS-CoV-2
Detecting SARS-CoV-2 immune response with an estimated accuracy of nearly 100%.
High sensitivity and specifity targeting highly antigenic structural and non-structural proteins.
Very early antibody detection from the symptoms onset identifying IgG, IgA and IgM immunoglobulins.
Our goal is to improve serology testing performance by innovating and adapting new technology to collaborate building meaningful clinical investigation.
We strongly believe validity and realiability of assessment methods must be the most important characteristics of a well- designed assessment procedure, and so we build our workflows in order to achieve the highest quality in all our products and devices.
CE/IVD kits are only suitable for clinical use in European Union and countries with EU conformity recognition agreements. Manufactured in Spain by Immunostep under CSIC Patent Licence.